Recent Developments, Liquidity and Management's Plans (Details Narrative) - Subsequent Event [Member] - USD ($) |
Mar. 23, 2020 |
Mar. 19, 2020 |
|---|---|---|
| Cash and marketable securities | $ 8,800,000 | |
| Restricted cash | 115,094 | |
| Working capital | $ 8,300,000 | |
| Cystron Biotech, LLC [Member] | ||
| Ownership pecentage | 100.00% |
| X | ||||||||||
- Definition Working capital. No definition available.
|
| X | ||||||||||
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of investment in marketable security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|